ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 85 filers reported holding ACLARIS THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $18,000 | -82.5% | 3,277 | -76.6% | 0.00% | – |
| Q4 2018 | $103,000 | – | 13,987 | +38752.8% | 0.00% | – |
| Q3 2018 | $0 | – | 36 | +3500.0% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 1 | -99.9% | 0.00% | – |
| Q1 2018 | $18,000 | -18.2% | 1,049 | +19.2% | 0.00% | – |
| Q4 2017 | $22,000 | -89.7% | 880 | -89.4% | 0.00% | -100.0% |
| Q3 2017 | $214,000 | -28.7% | 8,271 | -25.1% | 0.00% | 0.0% |
| Q2 2017 | $300,000 | +2627.3% | 11,040 | +2828.4% | 0.00% | – |
| Q1 2017 | $11,000 | -84.5% | 377 | -85.5% | 0.00% | – |
| Q4 2016 | $71,000 | – | 2,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |